AZAmir Mohammad Zargar

Amir Mohammad Zargar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amir Mohammad Zargar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    HLA-KIRs interactions in modulating natural killer cell responses against viral hepatitis: a concise review

    by Ata Shirizadeh, Amir Mohammad Zargar, Tohid Kazemi, Ghasem Solgi

    Killer immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) molecules play an essential role in regulating immune responses against hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. HLA-KIRs interactions are crucial for activating and inhibiting the natural killer (NK) cell system through a modulation that shapes these cells to kill infected cells and release cytokines. Regulation underlies the anti-viral function of the NK cell and profoundly affects viral clearance, immune evasion, and the course of disease. Activating KIRs such as KIR2DS1 and KIR3DS1 cooperate with specific HLA ligands in boosting NK cell responses against the virus, thereby facilitating viral elimination. In contrast, inhibitory KIRs like KIR2DL1 and KIR3DL1 bind to HLA-C2 and HLA-Bw4, respectively, imposing a dampening influence on NK cell activation, which allows the virus to persist and progress to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). These variations in KIRs and HLA genes will also affect an individual’s susceptibility to infections, disease severity, and their response to antiviral therapies. Observation of the role of KIRs and their interaction with HLA at the immunogenetic level provides valuable insight into host-virus dynamics and opens up many therapeutic avenues. Targeting immunotherapies toward NK cell pathways and developing personalized medicine may boost antiviral immune responses and improve treatment outcomes in chronic viral hepatitis patients. This review recognizes HLA-KIRs interactions as potent biomarkers for disease progression and determining treatment strategies.


  • Open Access

    Oxidative Stress in Fatty Liver Disease with Metabolic and Non-metabolic Etiologies

    by Zahra Ali, Amir Mohammad Zargar, Erfan Golestannejad, Sina Mohagheghi

    Background: Fatty liver disease (FLD) is classified into metabolic dysfunction-associated fatty liver disease (MAFLD) and non-MAFLD based on the presence of metabolic abnormalities. The pathophysiology of FLD is complex; however, oxidative stress (OS) seems to play a significant role in its progression. Objectives: This study examined oxidative stress markers linked to FLD. Methods: A total of 64 patients with FLD, including 38 MAFLD and 26 non-MAFLD patients, respectively, were evaluated and compared with 22 healthy individuals. To assess oxidative stress, in addition to the activities of catalase (CAT), glutathione peroxidase (GPx), and superoxide dismutase (SOD) enzymes, total oxidant status (TOS), malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured in the serum of the participants. Results: It was found that TOS, MDA, and TAC levels in the serum were significantly higher in the FLD group compared to the healthy individuals. Notably, these increases were more pronounced in the MAFLD group compared to the non-MAFLD group. Additionally, CAT and GPx enzyme activities were significantly elevated in patients with FLD than in the control group. The MAFLD group exhibited the highest CAT enzyme activity, while the non-MAFLD group demonstrated the highest GPx enzyme activity. Conversely, serum SOD enzyme activity was decreased across all studied groups, with no significant differences observed between them. Conclusion: Patients with MAFLD and non-MAFLD exhibit an imbalance in their oxidative stress systems. It appears that CAT and GPx enzymes probably play crucial roles in the antioxidant defense mechanisms in these patients, respectively.

  • Investigating the expression of CD180, LY96, VCAM-1, and CSF2RB in the lipopolysaccharide response pathway across different liver cirrhosis etiologies

    by Shayan Marhamati, Zahra Ali, Amir Mohammad Zargar, Sina Mohagheghi

    Background Liver cirrhosis represents a significant global health burden with diverse etiological factors. The lipopolysaccharide response pathway is critical in liver disease development. This study investigates this pathway in liver cirrhosis associated with various etiologies, including nonalcoholic steatohepatitis, alcohol consumption, viral infections, autoimmune disorders, and cholestatic disorders. Methods and results The GSE25097 and GSE54238 microarray datasets were retrieved from the Gene Expression Omnibus (GEO) database using R software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed on the overlapping Differentially Expressed Genes (DEGs). Gene expression was determined by RT-qPCR, and protein expression was determined by Western blot. A total of 499 overlapping DEGs were identified between the two datasets. Then, the GOBP enrichment analysis subsequently discovered the lipopolysaccharide response pathway, highlighting genes such as CD180, LY96, VCAM-1, and CSF2RB. Based on bioinformatics analysis, the expressions of all mentioned genes were elevated in cirrhotic samples. However, experimental results showed an increase only in CD180 gene expression. Our research has shown that the expressions of the LY96, VCAM-1, and CSF2RB genes were elevated only in PSC cirrhosis. The PSC group had an elevation in LY96 protein expression. On the other hand, all the gene expressions significantly decreased in NASH cirrhosis, although only the VCAM-1 protein expression was reduced in NASH cirrhosis. Conclusions The response to the lipopolysaccharide pathway has a complicated role in liver disease pathogenesis. While gene expression of pathway components increases in cholangitis-related cirrhosis, it decreases in NASH-associated cirrhosis.


  • Open Access

    Differential levels of thyroid hormones, cortisol, and apolipoprotein M in fatty liver disease

    by Amir Mohammad Zargar, Heidar Tayebinia, Maryam Hasanzarrini, Mohamad Bahiraei, Sina Mohagheghi

    Objectives: Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated fatty liver disease (MAFLD), can also manifest in patients classified as non-MAFLD who do not meet MAFLD criteria. The involvement of cortisol and thyroid hormones may play a role in the pathogenesis of FLD by modifying the metabolism of specific lipoproteins, particularly apolipoprotein M ( Apo M ). This study investigated cortisol and thyroid hormones levels and Apo M gene expression in white blood cells (WBCs) of individuals with MAFLD, non-MAFLD, and healthy controls. Methods: The serum and WBCs of the study subjects were collected from patients with FLD (n=99) including 58 MAFLD and 41 non-MAFLD and healthy individuals (n=23). To investigate the gene expression of Apo M and thyroid and cortisol hormones, qRT-PCR and ELISA methods were used, respectively. Results: The Apo M gene expression was significantly lower in FLD patients, both non-MAFLD, and MAFLD patients compared to the control group (pApo M gene expression also cortisol and thyroid hormones levels in non-MAFLD patients were milder than MAFLD patients when compared to the control. Also, likely Apo M may be involved in FLD pathogenesis.